Advertisement
ProteinSimple
ProteinSimple

The Scientist

» clinical trials

Most Recent

image: More Doubt Cast Over Cardiac Stem Cells

More Doubt Cast Over Cardiac Stem Cells

By | May 7, 2014

Contrary to previous reports, cell lineage tracing reveals stem cells in the heart rarely contribute to new muscle.

0 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Updated Review: Tamiflu Is a Bust

Updated Review: Tamiflu Is a Bust

By | April 10, 2014

After finally getting their hands on full clinical study reports, independent reviewers say the antiviral drug is ineffective.

6 Comments

image: The Promise of Nanomedicine

The Promise of Nanomedicine

By | April 8, 2014

At AACR, scientists discuss the growing interest in nanotechnology and how it can be used to study, diagnose, and treat cancer.

0 Comments

image: Epigenetic Cancer Therapy Clears Phase I

Epigenetic Cancer Therapy Clears Phase I

By | April 7, 2014

Investigational drug that inhibits proteins involved with epigenetic regulation shows activity against certain blood cancers in an early-stage clinical trial.

0 Comments

image: Making Better Mesenchymal Stem Cells

Making Better Mesenchymal Stem Cells

By | March 27, 2014

Scientists generate a new crop of stem cells that show therapeutic potential in mouse models of autoimmune diseases.

0 Comments

image: Saving Failing Hearts

Saving Failing Hearts

By | March 12, 2014

Inhibiting a small regulatory RNA appears to improve cardiac function in mice with surgically induced heart problems.

0 Comments

image: FDA Considers Three-Way Babies

FDA Considers Three-Way Babies

By | February 26, 2014

The agency is soliciting opinions on a new technology that has the potential to circumvent mitochondrial diseases by producing embryos using DNA from three people.

1 Comment

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Unauthorized HIV Trial Leader Fined

Unauthorized HIV Trial Leader Fined

By | February 3, 2014

A Spanish researcher faces a penalty after conducting a study for which he never obtained proper approvals or insurance.

0 Comments

Advertisement
Lonza
Lonza

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  3. Biologist Resigns Amid Sexual Misconduct Probe
  4. Turning Tumor Cells Against Cancer
Advertisement
Advertisement
Life Technologies